Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
Stock Information for Palatin Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.